Insider Trading & Ownership - Adawi Kamal

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Adawi Kamal
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-04
Sale
2024-03-06
4:05 pm
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
12,784$1.9092$24,407243,749
(Direct)
View
2024-02-06
Sale
2024-02-08
4:05 pm
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
6,738$1.9491$13,133181,533
(Direct)
View
2023-03-02
Sale
2023-03-03
4:38 pm
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
3,667$2.2993$8,432188,271
(Direct)
View
2023-02-08
Sale
2023-02-10
4:05 pm
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
5,821$2.6921$15,67191,938
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-20
Option Award
2024-02-22
4:11 pm
N/A
N/A
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
75,000$0256,533
(Direct)
View
2023-02-27
Option Award
2023-03-01
4:06 pm
N/A
N/A
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
100,000$0191,938
(Direct)
View
2022-03-01
Tax Withholding
2022-03-02
4:39 pm
N/A
N/A
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
3,241$7.1297,759
(Direct)
View
2022-02-04
Option Award
2022-02-08
4:20 pm
N/A
N/A
EXAGEN INC.XGNAdawi Kamal
CFO and Corporate Secretary
63,500$0101,000
(Direct)
View
2021-02-23
Option Award
2021-02-25
5:05 pm
N/A
2031-02-22
EXAGEN INC.XGNAdawi Kamal
Chief Financial Officer
50,000$050,000
(Direct)
View
2020-01-09
Option Award
2020-01-09
5:08 pm
N/A
2030-01-08
EXAGEN INC.XGNAdawi Kamal
Chief Financial Officer
52,500$052,500
(Direct)
View
2019-09-18
Option Award
2019-09-20
6:58 pm
N/A
2029-09-17
EXAGEN INC.XGNAdawi Kamal
Chief Financial Officer
21,635$021,635
(Direct)
View

Ownership
2019-09-18
9:23 pm
N/A
2028-10-05
EXAGEN INC.XGNAdawi Kamal
Chief Financial Officer
0$084,162
(Direct)
View